Leo Grady Joins Paige.AI as Chief Executive Officer

Seasoned Machine Learning and Medical Imaging Technology Executive
Joins Paige.AI
After Leading Successful Product Development
Efforts at HeartFlow

NEW YORK–(BUSINESS WIRE)–Paige.AI, the leading start-up focused on transforming clinical
diagnosis and treatment in pathology and oncology through the use of
artificial intelligence (AI), today announced that Dr. Leo Grady has
joined the company as Chief Executive Officer and a member of its Board
of Directors.

Grady is a seasoned healthcare technology leader with more than 15 years
of experience in prototyping, developing, and bringing to market some of
the industry’s most advanced machine learning, computer vision, and
medical imaging technologies and products. Prior to joining Paige.AI,
Grady was Senior Vice President of Engineering for HeartFlow, a leading
medical technology company recently valued at more than $1.5 billion,
that leverages deep learning to transform the way cardiac disease is
diagnosed and treated.

Paige.AI was launched in 2018 based on technology developed by its
Co-Founder and Chief Scientific Officer, Dr. Thomas Fuchs, and a license
agreement with Memorial Sloan Kettering Cancer Center (MSK). Paige.AI is
well on its way to digitizing five million pathology slides from MSK’s
enormous archive, giving the company an unparalleled database on which
to build its AI. In its first year, Paige.AI has hired an outstanding
group of AI scientists and software engineers who are working to create
fundamental advances in computational pathology, initially focused on
developing a full suite of modules and products to serve the needs of
diagnostic pathologists around the world.

The Board is thrilled to welcome Leo to the Paige.AI team as our new
CEO,” said Jim Breyer, CEO of Breyer Capital, a premier global venture
capital firm and a lead Paige.AI investor. “Leo is an accomplished
healthcare technology executive who has successfully led the development
and commercialization of transformative technologies rooted in medical
imaging and machine learning. With those strong credentials in both the
business and scientific arenas, Leo is highly regarded and ideally
positioned to help build on Paige.AI’s uniquely compelling foundation of
world-class AI, data at scale, and excellent clinical expertise.”

Leo’s demonstrated business and leadership acumen at cutting-edge
healthcare technology organizations, grounded in his capabilities as a
scientist and engineer, make him a great cultural fit and the ideal CEO
to help us take Paige.AI to the next level,” said Fuchs. “The entire
team looks forward to working with him in advancing our mission of
developing AI and machine learning to help pathologists and physicians
deliver better, more customized care for cancer patients around the
world.”

I am deeply honored to have the opportunity to lead and work alongside
Paige.AI’s growing team of the industry’s best and brightest minds, and
I appreciate the confidence the Board and my new colleagues have placed
in me,” said Grady. “Technology innovation in healthcare is taking huge
steps forward every day, and Paige.AI is leading the charge by applying
AI and machine learning to transform how doctors diagnose and treat
cancer. We have a rare opportunity at Paige.AI to provide technology
that helps doctors achieve the triple aim of healthcare: improved
patient care, improved patient experience and lowered costs. Paige.AI’s
mission is one of great purpose and promise and I look forward to
working with the team to help realize this company’s enormous potential.”

About Dr. Leo Grady

Dr. Leo Grady is a seasoned healthcare technology leader with more than
15 years of experience in prototyping, developing, and bringing to
market some of the industry’s most advanced machine learning, computer
vision, and medical imaging technologies and products. Grady was most
recently Senior Vice President of Engineering for HeartFlow, where he
led full stack technology and product development efforts for
HeartFlow’s cardiovascular software. He was responsible for establishing
modern product development techniques in the context of a medical
device, driving the HeartFlow IP portfolio, and oversaw all aspects of
tactical product development execution. Before joining HeartFlow in
2012, Grady served in a variety of scientific and leadership roles at
Siemens.

Grady is internationally recognized for his scientific work on advanced
technology for medical imaging and machine learning, has published two
books and over 100 peer-reviewed journal and conference papers, and has
over 300 issued or pending patents worldwide. In 2014, Grady was
inducted as a Fellow in the American Institute for Medical and
Biological Engineering. In 2012, he was the recipient of the Edison
Patent Award in medical imaging. He received a B.Sc. degree in
Electrical Engineering at the University of Vermont and a Ph.D. in
Cognitive and Neural Systems from Boston University.

About Paige.AI

Paige.AI is the leading start-up focused on building the best artificial
intelligence in clinical medicine to transform how doctors diagnose and
treat cancer. Based in New York, Paige.AI is bringing together the
world’s leading experts in AI, computational pathology and clinical
practice to improve patient care through a quantum leap forward in
efficacy and efficiency. For more information, please visit: https://paige.ai.

Contacts

Sard Verbinnen & Co.
Matt Benson/Cameron Seligmann
212-687-8080

error: Content is protected !!